The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study
Clinical trial NCT01949363 · COMPLETED
Trial details
- NCT number
- NCT01949363
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-02-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.